Treatment of toxoplasmosis: Current options and future perspectives

Area of Science:

• Infectious Diseases
• Parasitology
• Medical Research

Background:

• Toxoplasmosis is a global parasitic infection affecting approximately one-third of the human population.
• Severe outcomes are frequently observed in neonates and immunocompromised patients.
• Despite diagnostic advancements, therapeutic options for toxoplasmosis have seen minimal evolution.

Purpose of the Study:

• To review current clinical trials and treatment practices for toxoplasmosis.
• To explore future research directions and potential novel therapies.
• To provide an overview of the therapeutic landscape for this parasitic disease.

Main Methods:

• Literature review of clinical trials.
• Analysis of current treatment guidelines and practices.
• Synthesis of ongoing research findings.

Main Results:

• Diagnostic methods for toxoplasmosis have improved significantly.
• Therapeutic strategies for toxoplasmosis have remained largely unchanged for many years.
• Ongoing research is exploring new avenues for treatment.

Conclusions:

• There is a critical need for the development of more effective therapeutic schemes for toxoplasmosis.
• Future research holds promise for advancing treatment options.
• Addressing the stagnation in therapeutic evolution is crucial for managing severe toxoplasmosis cases.